Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON37142Active, not recruiting
Randomised, double-blind trial of lipopolysaccharide endotoxin (4 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Inflammatory response dose relationship, Coagulation response and 2 more. Started Aug 2012; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON37142.